Position in NBIX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,159,110
+$340,930 QoQ
Shares Held
18,744
-12.4% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#25
of 205 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $14,160,724 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
9,856 | $5,340,273 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
18,744 | $3,159,110 | |
| 3 | VTRS |
Viatris Inc
|
74,483 | $1,182,785 | |
| 4 | ZTS |
Zoetis Inc.
|
13,254 | $952,428 | |
| 5 | HLN |
Haleon plc
|
101,892 | $950,650 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
35,173 | $563,820 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
4,251 | $471,603 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
5,474 | $350,060 |
All Filings in NBIX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,159,110 | 18,744 | Shares | Other | 2026-07-20 | |
| 2026-03-31 | $2,818,180 | 21,392 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $2,486,417 | 17,531 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $2,053,196 | 14,626 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $913,012 | 7,264 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $459,321 | 4,153 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $519,792 | 3,808 | Shares | Sole | 2025-01-15 | |
| 2023-09-30 | $278,887 | 2,479 | Shares | Sole | 2023-11-07 | |
| No filing history on record for this holder in this stock. | ||||||